expert perspectives

in Gastrointestinal Stromal Tumors

Expert Perspectives in Gastrointestinal Stromal Tumors to Cover Key Topics in GIST Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Gastrointestinal Stromal Tumors will feature selected topics in Gastrointestinal Stromal Tumors that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Michael C. Heinrich, MD

Professor of Medicine
Professor of Cell and Developmental Biology
OHSU Knight Cancer Institute
Oregon Health & Science University School of Medicine
Portland, OR

Arun Singh, MD

Associate Professor
David Geffen School of Medicine
UCLA Medical Center
Santa Monica, CA

Jonathan C. Trent, MD, PhD

Professor of Medicine
Associate Director for Clinical Research
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, FL


Community-Selected Topics: 

Expert Roundtables

    Novel Treatments for Patients With Advanced Gastrointestinal Stromal Tumors
    Advances in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors
    Optimization of Therapeutic Strategies for Patients With Gastrointestinal Stromal Tumors
    Gastrointestinal Stromal Tumors: Managing Side Effects With Targeted Therapies

Clinical Topic Updates 

    Immunotherapy and Gastrointestinal Stromal Tumors
    Treatment of Gastrointestinal Stromal Tumors With PDGFRA D842V Mutations
    Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
    Early Drug Development: Promising New Treatments for Gastrointestinal Stromal Tumors

Patient Care Perspectives 

    Differential Diagnosis of Gastrointestinal Stromal Tumors
    Pathologic and Molecular Risk Stratification in Patients With Gastrointestinal Stromal Tumors
    Counseling Newly Diagnosed Patients With Gastrointestinal Stromal Tumors
    Impact of Gastrointestinal Stromal Tumors on Quality of Life

More in GIST

Thumb

GIST

New Directions for Gastrointestinal Stromal Tumor Clinical Research

Clinical Topic Updates by Arun Singh, MD

Newer targeted therapies for patients with gastrointestinal stromal tumors (GIST) are being developed to inhibit primary and drug-resistant KIT/PDG...READ MORE

Thumb

GIST

Resistance-Conferring Mutations With First-Generation Tyrosine Kinase Inhibitors

Clinical Topic Updates by Jonathan C. Trent, MD, PhD

Imatinib has revolutionized the treatment of gastrointestinal stromal tumors (GIST); however, resistance to tyrosine kinase inhibition is a continu...READ MORE

Thumb

GIST

Predicting Gastrointestinal Stromal Tumor Growth and Spread Post Surgery

Patient Care Perspectives by Michael C. Heinrich, MD

The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat...READ MORE

More In Oncology

GIST

Gastrointestinal Stromal Tumors: Managing Side Effects of Targeted Therapies

Expert Roundtables
by Michael C. Heinrich, MD; Arun Singh, MD; and Jonathan C. Trent, MD, PhD

GIST

Optimization of Therapeutic Strategies for Patients With Gastrointestinal Stromal Tumors

Expert Roundtables
by Michael C. Heinrich, MD; Arun Singh, MD; and Jonathan C. Trent, MD, PhD

GIST

The Impact of Gastrointestinal Stromal Tumors on Quality of Life

Patient Care Perspectives
by Jonathan C. Trent, MD, PhD